相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
Hong M. Moulton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
B. Wu et al.
GENE THERAPY (2010)
Efficient Bypass of Mutations in Dysferlin Deficient Patient Cells by Antisense-Induced Exon Skipping
Nicolas Wein et al.
HUMAN MUTATION (2010)
Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
Alessia David et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
Hans Heemskerk et al.
MOLECULAR THERAPY (2010)
Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping
Aurelie Goyenvalle et al.
MOLECULAR THERAPY (2010)
The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009
F. Muntoni
NEUROMUSCULAR DISORDERS (2010)
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy
Hans Heemskerk et al.
OLIGONUCLEOTIDE THERAPEUTICS (2009)
Antisense Therapeutics for Neurofibromatosis Type 1 Caused by Deep Intronic Mutations
Eva Pros et al.
HUMAN MUTATION (2009)
A Deep Intronic Mutation in FGB Creates a Consensus Exonic Splicing Enhancer Motif That Results in Afibrinogenemia Caused by Aberrant mRNA Splicing, Which Can Be Corrected In Vitro With Antisense Oligonucleotide Treatment
Ryan L. Davis et al.
HUMAN MUTATION (2009)
Antisense Oligonucleotide Treatment for a Pseudoexon-Generating Mutation in the NPC1 Gene Causing Niemann-Pick Type C
Laura Rodriguez-Pascau et al.
HUMAN MUTATION (2009)
Exon Skipping-Mediated Dystrophin Reading Frame Restoration for Small Mutations
Pietro Spitali et al.
HUMAN MUTATION (2009)
Functional Analysis of Three Splicing Mutations Identified in the PMM2 Gene: Toward a New Therapy for Congenital Disorder of Glycosylation type IA
Ana I. Vega et al.
HUMAN MUTATION (2009)
Mutational Spectrum of DMD Mutations in Dystrophinopathy Patients: Application of Modern Diagnostic Techniques to a Large Cohort
Kevin M. Flanigan et al.
HUMAN MUTATION (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Cell Based Therapy for Duchenne Muscular Dystrophy
Andrea Farini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
By-passing the nonsense mutation in the 4(CV) mouse model of muscular dystrophy by induced exon skipping
Chalermchai Mitrpant et al.
JOURNAL OF GENE MEDICINE (2009)
Modification of Alternative Splicing of Mcl-1 Pre-mRNA Using Antisense Morpholino Oligonucleotides Induces Apoptosis in Basal Cell Carcinoma Cells
Jeng-Jer Shieh et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Variation in GIGYF2 is not associated with Parkinson disease
W. C. Nichols et al.
NEUROLOGY (2009)
Antisense oligonucleotide therapeutics for iron-sulphur cluster deficiency myopathy
Gittan Kollberg et al.
NEUROMUSCULAR DISORDERS (2009)
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides
Charlton Cooper et al.
NUCLEIC ACIDS RESEARCH (2009)
RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
Saovaros Svasti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy
Olga L. Gurvich et al.
ANNALS OF NEUROLOGY (2008)
Assessment of the feasibility of exon 45-55 multiexon skipping for duchenne muscular dystrophy
Laura van Vliet et al.
BMC MEDICAL GENETICS (2008)
Combining stem cells and exon skipping strategy to treat muscular dystrophy
Mirella Meregalli et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice
Michela Alessandra Denti et al.
HUMAN GENE THERAPY (2008)
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2008)
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis
Kasper Thorsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
An endogenous TNF-α antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models
Maria A. Graziewicz et al.
MOLECULAR THERAPY (2008)
In vivo correction of a Menkes disease model using antisense oligonucleotides
Erik C. Madsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
Marcella Neri et al.
NEUROMUSCULAR DISORDERS (2007)
U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites
Hideki Uchikawa et al.
JOURNAL OF HUMAN GENETICS (2007)
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
BMC MEDICAL GENETICS (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides
Liutao Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Liat Linde et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63 % of patients with Duchenne muscular dystrophy
Christophe Beroud et al.
HUMAN MUTATION (2007)
Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
Bernard Khoo et al.
BMC MOLECULAR BIOLOGY (2007)
Antisense experiments demonstrate an Exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein
Xiaoyu Tang et al.
ONCOLOGY RESEARCH (2007)
Pathophysiology of duchenne muscular dystrophy: Current hypotheses
Nicolas Deconinck et al.
PEDIATRIC NEUROLOGY (2007)
Targeted skipping of a single exon harboring a premature termination codon mutation: Implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients
Maki Goto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G. McClorey et al.
GENE THERAPY (2006)
Exploring the frontiers of therapeutic dxon skipping for Duchenne muscular dystrophy by double targeting within one or multiple dxons
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides
F Vetrini et al.
HUMAN MUTATION (2006)
Modification of MyD88 mRNA splicing and inhibition of IL-1β signaling in cell culture and in mice with a 2′-β-methoxyethyl-modified oligonucleotide
Timothy A. Vickers et al.
JOURNAL OF IMMUNOLOGY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Analysis of prostate-specific membrane antigen splice variants in LNCap cells
Tiffany Williams et al.
OLIGONUCLEOTIDES (2006)
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells
D Skuk et al.
MOLECULAR THERAPY (2004)
Targeted exon skipping in transgenic hDMD mice:: A model for direct preclinical screening of human-specific antisense oligonucleotides
M Bremmer-Bout et al.
MOLECULAR THERAPY (2004)
Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of Duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon
A Surono et al.
HUMAN GENE THERAPY (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense
A Aartsma-Rus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Advances in Duchenne muscular dystrophy gene therapy
JCT van Deutekom et al.
NATURE REVIEWS GENETICS (2003)
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu et al.
NATURE MEDICINE (2003)
Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle
P Dunant et al.
MUSCLE & NERVE (2003)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents
DR Mercatante et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient
Y Takeshima et al.
BRAIN & DEVELOPMENT (2001)
Correction of alternative splicing of tau in frontotemporal dementia and Parkinsonism linked to chromosome 17
B Kalbfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
JCT van Deutekom et al.
HUMAN MOLECULAR GENETICS (2001)
Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-α chain
JG Karras et al.
BIOCHEMISTRY (2001)
分享论文
